COSCIENS Biopharma Inc. financial data

Symbol
CSCI on Nasdaq
Industry
Pharmaceutical Preparations
Location
C/O Norton Rose Fulbright Canada Llp, 222 Bay Street, Suite 3000, Po Box 53, Toronto, Ontario, Canada
State of incorporation
Ontario, Canada
Fiscal year end
December 31
Former names
Aeterna Zentaris Inc. (to 8/7/2024), AETERNA LABORATORIES INC (to 5/25/2004)
Latest financial report
20-F/A - Q4 2023 - Jul 17, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.86M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 12.1M USD -14.1%
General And Administrative Expense 9.93M USD +14.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 7.03M USD -15.5%
Assets 31.8M USD -38%
Liabilities 18.8M USD -6.24%